EAM Investors, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$2,707,000
-27.1%
85,542
-10.5%
0.40%
-31.3%
Q2 2018$3,711,000
-25.3%
95,531
-46.9%
0.58%
-29.3%
Q1 2018$4,966,000
+724.9%
179,911
+439.8%
0.83%
+808.8%
Q2 2016$602,000
-10.0%
33,332
-5.5%
0.09%
-13.3%
Q1 2016$669,000
-38.6%
35,255
-13.6%
0.10%
-26.1%
Q4 2015$1,089,000
+7.1%
40,782
-2.2%
0.14%
-11.8%
Q3 2015$1,017,000
-36.3%
41,700
-18.6%
0.16%
-13.9%
Q2 2015$1,597,000
-52.3%
51,240
-77.7%
0.19%
-51.7%
Q1 2015$3,350,000230,2610.39%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders